New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry
Current diagnostic methods for prion diseases only work in late stages of the disease when neurodegeneration is irreversible. Therefore, biomarkers that can detect the disease before the onset of clinical symptoms are necessary. High-throughput discovery proteomics is of great interest in the search...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2024-12-01
|
| Sarja: | Veterinary Quarterly |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/01652176.2024.2424837 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|